Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

STRYKER CORPORATION

(SYK)
  Report
Real-time Estimate Cboe BZX  -  01:35:52 2023-02-02 pm EST
280.09 USD   +0.41%
09:24aNo-surprise rate hikes
MS
07:47aDA Davidson Adjusts Stryker's Price Target to $290 From $250, Maintains Buy Rating
MT
02/01Electronic Arts, WestRock fall; Stryker, Peloton rise
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Stryker to participate in the 5th Annual Evercore ISI HealthCONx Conference

11/03/2022 | 03:06pm EST

Kalamazoo, Michigan, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 5th Annual Evercore ISI HealthCONx Conference on Thursday, December 1, 2022.

Kevin Lobo, Chair and Chief Executive Officer and Jason Beach, Vice President, Investor Relations will represent the Company in a presentation scheduled for 8:50 a.m. Eastern Time.

A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com.  The webcast will be archived on the Investor Relations page of this site.

About Stryker

Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 100 million patients annually.  More information is available at www.stryker.com.

Contacts

For investor inquiries please contact:
Jason Beach, Vice President, Investor Relations at 269-385-2600 or jason.beach@stryker.com 

For media inquiries please contact:
Yin Becker, Vice President, Chief Corporate Affairs Officer at 269-385-2600 or yin.becker@stryker.com


All news about STRYKER CORPORATION
09:24aNo-surprise rate hikes
MS
07:47aDA Davidson Adjusts Stryker's Price Target to $290 From $250, Maintains Buy Rating
MT
02/01Electronic Arts, WestRock fall; Stryker, Peloton rise
AQ
02/01Morgan Stanley Adjusts Stryker Price Target to $280 From $260, Maintains Equal Weight R..
MT
02/01Truist Adjusts Stryker's Price Target to $275 From $257, Keeps Hold Rating
MT
02/01Baird Adjusts Stryker's Price Target to $287 From $240, Keeps Outperform Rating
MT
02/01Citigroup Adjusts Stryker's Price Target to $290 From $282, Keeps Buy Rating
MT
02/01BTIG Adjusts Price Target on Stryker to $281 From $268, Maintains Buy Rating
MT
02/01Loop Capital Adjusts Price Target on Stryker to $290 From $245, Maintains Buy Rating
MT
02/01Wells Fargo Adjusts Price Target on Stryker to $285 From $281, Maintains Overweight Rat..
MT
More news
Analyst Recommendations on STRYKER CORPORATION
More recommendations
Financials (USD)
Sales 2022 18 207 M - -
Net income 2022 2 595 M - -
Net Debt 2022 10 381 M - -
P/E ratio 2022 39,9x
Yield 2022 1,00%
Capitalization 106 B 106 B -
EV / Sales 2022 6,37x
EV / Sales 2023 5,77x
Nbr of Employees 46 000
Free-Float 98,2%
Chart STRYKER CORPORATION
Duration : Period :
Stryker Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends STRYKER CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Last Close Price 278,95 $
Average target price 273,15 $
Spread / Average Target -2,08%
EPS Revisions
Managers and Directors
Kevin A. Lobo Chairman, President & Chief Executive Officer
Glenn S. Boehnlein Chief Financial Officer & Vice President
Alan Douville Chief Information Officer & Vice President
Dana S. McMahon Chief Compliance Officer & Vice President
Howard E. Cox Director-Emeritus
Sector and Competitors
1st jan.Capi. (M$)
STRYKER CORPORATION14.09%105 563
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.6.65%19 384
SMITH & NEPHEW PLC1.31%12 067
INSPIRE MEDICAL SYSTEMS, INC.2.28%7 443
ENOVIS CORPORATION20.46%3 491
AXONICS, INC.-2.33%3 025